U.S. Cardiac Troponin Market Size - By Type (Troponin I and Troponin T), By Indication, By Setting, By End-User and By Region: Global Forecast, 2024 – 2033

  • 2023-12-29
  • 290
  • Healthcare & Life Sciences

Market Overview

U.S. Cardiac Troponin Market Size is predicted to develop at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2033, when it is projected to reach USD 7.9 billion, based on an average growth pattern. The market is estimated to reach a value of USD 2.1 billion in 2024.


SOURCE: We Market Research

A protein called cardiac troponin is present in the cardiomyocytes, or heart muscle cells. These cells cause the release of cardiac troponin into the bloodstream when the heart muscle is damaged, as happens during a heart attack. To diagnose and gauge the severity of heart problems, medical experts take cardiac troponin levels. Increased levels suggest stress or cardiac injury. Cardiac troponin is a highly specific and sensitive test than other cardiac biomarker test that helps identify myocardial infarction and other heart problems and informs treatment choices for improved patient outcomes.

The U.S. Cardiac Troponin market is influenced by many different factors. First off, the need for accurate diagnostic instruments like troponin testing is growing as the prevalence of cardiovascular disorders rises. Furthermore, developments in sensitive troponin tests promote their adoption by improving the accuracy of diagnosing heart-related diseases. Furthermore, the aging population plays a major role because heart exams are frequently needed for senior people. Because troponin is a critical biomarker for prompt intervention and lowers the rates of morbidity and death linked to cardiac problems, the increasing focus on early disease identification and management is driving the market's rise. The growth of the cardiac troponin market in the United States is fueled by these factors together.

Market Scope

Report Attributes


Market Size in 2024

USD 2.1 Billion

Market Forecast in 2033

USD 7.9 Billion

CAGR % 2024-2033


Base Year


Historic Data


Forecast Period


Report USP


Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Type, By Indication, By Setting, By End-user and By Region

Growth Drivers

The high incidence of cardiovascular diseases, including heart attacks and myocardial infarctions, has been a significant driver for the cardiac troponin market. Troponin is a crucial biomarker for the diagnosis and monitoring of cardiac conditions.

The aging population in the United States is associated with a higher risk of cardiovascular diseases. As the demographic landscape shifts toward an older population, there is a growing need for effective cardiac biomarkers like troponin for timely diagnosis and management.

Increased awareness among healthcare professionals and the general public about the importance of early detection and diagnosis of cardiovascular diseases has led to a higher demand for troponin testing.

Regional Scope

North America

Country Scope


U.S. Cardiac Troponin Industry: Dynamics & Restrains

Market Drivers

Rising Prevalence of Cardiovascular Diseases - The growing incidence of cardiovascular diseases (CVDs) is driving the U.S. Cardiac Troponin market. The incidence of CVDs is increasing as lifestyle factors fuel an increase in diseases like obesity and hypertension. Troponin tests are crucial for the diagnosis of heart problems and are used in both routine screenings and emergency scenarios. The need for sensitive and precise cardiac indicators like troponin is rising due to an aging population and greater awareness. The U.S. market for cardiac troponin is expanding as a result of this trend, which highlights the vital role these tests play in prompt diagnosis and addresses the mounting issues with cardiovascular health.

Increased Focus on Early Diagnosis and Prevention - The U.S. Cardiac Troponin market is being driven primarily by the growing focus on early detection and prevention. Proactive healthcare practices increase awareness of the significance of early identification of cardiovascular illnesses (CVDs). Because troponin tests are so sensitive at diagnosing heart damage, they are essential for spotting cardiac problems early on. Troponin is one of the most reliable and effective cardiac biomarkers, and its use in regular screenings and diagnostic protocols is increased by this emphasis on early intervention and preventive measures. As a result, this promotes the growth of the cardiac troponin market in the United States, which is consistent with the overall objective of proactive cardiovascular health management.

Market Restrains

Cost and Reimbursement Concerns - The cardiac troponin industry in the US has been severely impacted by concerns about payment and cost. In smaller healthcare facilities or in places with low resources, accessibility is restricted due to the high cost of troponin testing methods and equipment. Pricing and acceptance are further hampered by unfair or onerous reimbursement limits, which have an effect on the total use of troponin testing. The cardiac troponin market is not expanding in the United States due to this pricing barrier, which makes it impossible for the product to become a standard component of diagnostic procedures and stops it from expanding further. This lessens their potential impact on early cardiac diagnosis and patient care.

U.S. Cardiac Troponin Segmentation

Market- By Type Analysis

By Type, the U.S. Cardiac Troponin Market is Categories into Troponin I, Troponin T. The Troponin I segment accounts for the largest share of around 57% in 2022.

Troponin I is driven by its exceptional cardiac selectivity, which facilitates precise identification of myocardial damage. The need for it is driven by its enhanced sensitivity, wider clinical acceptance, and dependability in identifying problems related to the heart. Troponin I assay importance in the U.S. market for cardiac diagnosis is also attributed to technological improvements that have improved them.

The following segments are part of an in-depth analysis of U.S. Cardiac Troponin Market:

Market Segments


By Indication

·         Myocardial Infarction

·         Congestive Heart Failure

·         Acute Coronary Syndrome

·         Others

By Setting

·         Laboratory Testing

·         Point-of-Care (POC) Testing

By End-User

·         Hospitals & Clinics

·         Diagnostic Laboratories

·         Homecare Settings

·         Others

Pointers Covered

The U.S. Cardiac Troponin Market Analysis Report provides a comprehensive analysis of the market. The report discusses market segmentation, DROS, and the product portfolios of the key market player companies in the US industry. It also provides the launch or research of new drugs, moreover advancements in the sector including collaborations, mergers, and acquisitions, as well as the impact of the COVID-19 pandemic on the market. The study also offers insights into market trends and an analysis of industry dynamics.

Competitive Analysis

The U.S. Cardiac Troponin Market is dominated by a few large companies, such as

·         F. Hoffmann-La Roche Ltd.

·         bioMérieux SA

·         Abbott

·         Siemens Healthineers AG

·         PerkinElmer Inc.

·         Beckman Coulter, Inc.

·         LifeSign LLC.

There are some of the key trends that are shaping the competitive landscape of the U.S. Cardiac Troponin Market.

·         May 2021: In order to increase its market, share in the immunodiagnostics sector, PerkinElmer Inc. successfully acquired Immunodiagnostic Systems Holdings PLC.

·         April 2021: Roche has revealed five more applications for two Elecsys biomarkers: the high-sensitivity cardiac troponin T (cTnT-hs) test and N-terminal pro-brain natriuretic peptide.

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of U.S. Cardiac Troponin Market in 2024?

U.S. Cardiac Troponin Market was valued at USD 2.1 Billion in 2024.

What is the growth rate for the U.S. Cardiac Troponin Market?

U.S. Cardiac Troponin Market size will increase at approximate CAGR of 8.6% during the forecasted period.

Which are the top companies operating within the U.S. Cardiac Troponin Market?

Major companies operating within the U.S. Cardiac Troponin Market Are F. Hoffmann-La Roche Ltd., bioMérieux SA, Abbott, Siemens Healthineers AG, PerkinElmer Inc., Beckman Coulter, Inc., LifeSign LLC. and others.


Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI